Systemic bevacizumab appears to have significant promise and a low complication profile for the most treatment- resistant and aggressive forms of papillomatosis.
Adjuvant Therapies May Increase Time Between Surgeries for Recurrent Respiratory Papillomatosis
Recurrent respiratory papillomatosis is incurable with current treatment modalities, but adjuvant therapies should be used when surgery cannot control the disease.
Laryngeal Distribution of Recurrent Respiratory Papillomatosis
In untreated RRP patients presenting to three laryngology clinics, males had more anatomic sites affected by papilloma than females.